nct foxo4-dri PEPTIDE 2MG/5MG/10MG VIAL – UMBRELLA Labs FOXO4-DRI 10mg

Diagnostic criteria for ME/CFS The original neurological classification of ME/CFS In 1969, the World Health Organisation (WHO) classified ME/CFS as a neurological disease (44) based on the neurological features of the disease

Anti-Inflammatory Effects TB-500 has more direct and potent anti-inflammatory properties

Supplies Needed Quantities below assume an 812 week daily protocol with gradual titration (~200 mcg/day average)

Differences in cytokine profiles in ME/CFS are also well documented, but finding a consistent, stable, and replicable cytokine profile may not be possible

These remain speculative because this compound has also been found to inhibit tumor growth in several cell lines